LINC00358: A Drug Target / Disease Biomarker (G100874143)

Target Name: LINC00358

NCBI ID: G100874143

LINC00358

Other Name(s): Long intergenic non-protein coding RNA 358 | long intergenic non-protein coding RNA 358

LINC00358: A Drug Target / Disease Biomarker

LINC00358 is a protein that is expressed in various tissues throughout the body, including the brain, heart, kidneys, and liver. It is a key regulator of cell proliferation and has been implicated in a number of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

One of the most promising aspects of LINC00358 is its potential as a drug target. LINC00358 has been shown to interact with a wide range of molecules, including tyrosines, which are important signaling molecules that can promote cell growth and division. This suggests that LINC00358 could be a useful target for therapies that target cancer cells, neurodegenerative diseases, or other conditions that are characterized by uncontrolled cell growth.

In addition to its potential as a drug target, LINC00358 is also a promising biomarker for a number of diseases. For example, LINC00358 has been shown to be highly expressed in the brains of individuals with Alzheimer's disease, a neurodegenerative disorder that is characterized by the progressive loss of brain cells. This suggests that LINC00358 could be a useful biomarker for diagnosing and monitoring the progression of Alzheimer's disease.

Another potential application of LINC00358 is its role in cell signaling. LINC00358 has been shown to play a key role in regulating the formation of new blood vessels in the brain, which is important for the development and maintenance of the blood-brain barrier. This suggests that LINC00358 could be a useful target for therapies that aim to improve blood flow to the brain, such as those used to treat stroke or other neurological conditions.

In addition to its potential applications as a drug target and biomarker, LINC00358 is also of interest to researchers because of its relatively simple structure. LINC00358 is a small protein that is expressed in a wide range of tissues, which makes it relatively easy to study. This has allowed researchers to investigate the molecular mechanisms that regulate LINC00358 expression and to use it as a tool for understanding the underlying biology of many different diseases.

Overall, LINC00358 is a promising protein that has the potential to be a drug target and biomarker for a wide range of diseases. Its relatively simple structure and ability to interact with a wide range of molecules make it an attractive target for researchers to study, and its potential applications in the clinic are significant. Further research is needed to fully understand the role of LINC00358 in the biology of disease and to develop effective therapies based on its properties.

Protein Name: Long Intergenic Non-protein Coding RNA 358

The "LINC00358 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC00358 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets